Commentary

AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings

Hong Kong’s listing pathways provide issuers with flexibility and access to a sophisticated investor base.

Commentary

2 days ago

AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings

Hong Kong’s listing pathways provide issuers with flexibility and access to a sophisticated investor base.

Commentary

2 days ago

Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation

What it will find is a wealth-management industry anchored in formal channels rather than regulatory ambiguity.

Commentary

Hong Kong should build the Asia–Latin America investment corridor

The next corridor will be built by capital, contracts, governance, and trust.

Commentary

Why Hong Kong's carried interest reform matters, and why it isn't a zero-sum play

The question is what the reform enables for managers and families operating structures across jurisdictions.

Commentary

Medical centre expansion in Hong Kong: How to choose the right location

It is about choosing premises that can support safe operations, efficient fit-out, compliance, and business performance.

Commentary

The Claude ban is a crash course in digital resilience — and that’s good for Hong Kong bankers

This pushes bankers to think under pressure – the skill that differentiates a commoditised analyst from a strategic advisor.

Commentary

Getting governance right in Hong Kong’s regulatory environment

Rushing holding vehicles without aligning with SFC and cross-border regulations leads to listing roadblocks.

Commentary

Why the impact of AI is being underestimated and how it will transform business productivity in Hong Kong

AI is boosting productivity, opening new career paths, and challenging the status quo.

Commentary

The strategic decarbonisation model for Hong Kong real estate

The journey follows three distinct stages: Assess, implement, and scale.

Commentary

The survival playbook for the CEO amidst geopolitical conflicts

The global business landscape has shifted from fluid uncertainty to structural friction.

Commentary

The succession shift: Redesigning wealth structures for the next generation

Wealth that endures is not merely protected. It is understood.

Commentary

2026 biotech playbook: Hong Kong at the centre of China’s globalisation

Hong Kong increasingly provides durable, repeat access to capital for public biotech firms.

Commentary

Navigating Hong Kong’s regulatory landscape: a challenging and rewarding endeavour

The city offers access to growth markets within a familiar common law framework.

Commentary

Wellness craze: Emerging growth for commercial space

Fitness operators are emerging as strategic, value-adding tenants.

Commentary

Hidden licensing hurdles affecting Hong Kong’s biotech ambitions

Hong Kong's approach remains fragmented, with each university applying its own policies and risk tolerance.

Commentary

Strategic location tips for playgroups and education centres

As more Hong Kong parents place greater emphasis on early childhood education, demand for high-quality playgroups and toddler learning centres continues to rise.

Commentary

Innovating CSDs: What Hong Kong can learn from Euroclear Cash+

Cash+ and similar offerings democratise scrip dividend arbitrage.

Commentary

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Commentary

Thought Leadership Centre

Most Read

Resource Center

Print Issue

Awards

Videos

Partner Sites